FDA Approves Flavored Vapes; BAT Outlook Positive

FDA Greenlights First Fruit-Flavored E-Vapor Products Since 2020

The U.S. Food and Drug Administration has officially approved applications from Glas Inc. for its fruit-flavored e-vapor products, including mango and blueberry. According to analysis from Jefferies, this marks the first time such products have received FDA approval since a widespread ban was enacted in 2020.

Market Landscape and Illicit Trade

Following the 2020 ban on non-tobacco and non-menthol flavors, the market saw a surge in illicit fruit-flavored products, which grew to represent approximately 65-75% of total U.S. e-vapor volumes. Meanwhile, legal competitors restricted to tobacco and menthol flavors experienced volume declines.

Potential Impact on Major Tobacco Companies

Jefferies analysts believe the creation of a legal, regulated market for flavored e-vapes is a positive development for British American Tobacco (BTI). As the largest player with a 41% market share in the tracked U.S. e-vapor channel as of April 2026, BAT is well-positioned to benefit. This decision may also signal a renewed focus on reviewing Next-Gen Nicotine Products, potentially affecting pending applications from Philip Morris (PM) and Altria (MO).

Summary and Outlook

The FDA's approval could significantly reshape the competitive landscape of the U.S. e-vapor market by shifting volume from the illicit market to regulated channels. Investors will be closely watching for further approvals and the strategic responses of major industry players like British American Tobacco.

FAQ

Q: Why is the FDA's approval of flavored e-vapes significant?
A: It is the first approval for fruit-flavored e-vapor products since a 2020 ban, creating a legal pathway that could challenge the dominant illicit market.

Q: Which company is expected to benefit the most?
A: According to Jefferies, British American Tobacco (BTI) stands to benefit due to its leading 41% market share in the U.S. e-vapor channel.

Source: Investing.com